Rewriting the
story of aging.

Our focus

We target genomic instability — the source of chronic disease and reduced lifespan.

As we age, our cells accumulate DNA damage that erodes the integrity of the genome. This genomic instability drives cancer, chronic disease, and the decline of healthy lifespan. Valley Biosciences develops therapies directed at the targets of genomic instability, working toward a future where treatment becomes prevention and lifespan is extended.